5mg with 2mL = 2,500mcg/mL
In some embodiments, the formulations described herein have a pH and/or practical osmolarity as described herein, and have a concentration of active pharmaceutical ingredient from about 0.0001% to about 60%, from about 0.001% to about 40%, from about 0.01% to about 20%, from about 0.01% to about 10%, from about 0.01% to about 7.5%, from about 0.01% to about 6%, from about 0.01 to about 5%, from about 0.1 to about 10%, or from about 0.1 to about 6% of the active ingredient by weight of the formulation
References: Primary Withdrawal Study (107 patients): Dick P, Costa C, Fayolle K, Grandjean ME, Khoshbeen A, Tissot R
TB-500 Pharmacokinetics and Systemic Distribution TB-500 enters systemic circulation within 30 minutes of subcutaneous injection, reaching peak plasma concentration between 46 hours regardless of injection site or time of day
Get the details in our article coffee and brain health